Home
/ FlexDex
/ Competitors

FlexDex Competitors and Similar CompaniesClear all

FlexDex's competitors and similar companies include Briteseed, Eximis Surgical, NuVasive and Amplitude Surgical.

	FlexDex FlexDex is a company that designs, develops, and manufactures invasive surgery systems.	Briteseed Briteseed is a medtech company that develops surgical instruments for the operating room.	Eximis Surgical Eximis Surgical is a technology company which develops medical devices to enable minimally invasive surgery with a neat specimen removal protocol.	NuVasive NuVasive is a company that provides surgery transformation and clinical support solutions for the healthcare industry.	Amplitude Surgical Amplitude Surgical SA is a France-based company engaged in the field of orthopedic surgeries.
Founding Date	Founding Date 2007	Founding Date 2013	Founding Date 2014	Founding Date 1997	Founding Date N/A
Type	Type Private	Type Private	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare medical devices surgical solutions	Tags Healthcare medical devices medical imaging medtech surgical solutions	Tags Healthcare Technology healthtech medical devices oncology surgical solutions	Tags Healthcare healthtech medical devices surgical solutions	Tags Healthcare healthtech medical devices surgical solutions
Locations	Locations Brighton, US HQ	Locations Chicago, US HQ	Locations Louisville, US HQ	Locations San Diego, US HQ Melbourne, AU Barueri, BR Bogotá, CO Bremen, DE Milan, IT Tokyo, JP see more	Locations Valence, FR HQ North Sydney, AU Stepney, AU Nivelles, BE Nieder Olm, DE Bunkyo City, JP see more
Employees	Employees 2116% decrease	Employees 1115% decrease	Employees 8	Employees 3,0003% increase	Employees 434
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.2b (FY, 2022)	Revenue (est.) €106m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $336.5m (FY, 2022)	Cost of goods €21.3m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $865.4m (FY, 2022)	Gross profit €85.8m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income $40.4m (FY, 2022)	Net income €1.5m (FY, 2024)
Funding
Latest funding round	Latest funding round $ 5m (almost 10 years ago)	Latest funding round $ 2m (almost 13 years ago)	Latest funding round $ 7.5m (over 7 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 8.8m	Total funding raised $ 2m	Total funding raised $ 13.8m	Total funding raised $ 65.3m	Total funding raised N/A